News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
PureTech Secures Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
Thursday, March 14, 2024PureTech Health plc a clinicalstage biotherapeutics company has announced that the US Food and Drug Administration has granted orphan drug designation to LYT for the treatment of AML
Prilenia Plans to Seek Marketing Authorization Application (MAA) Approval for Pridopidine in Huntington’s Disease from the EU
Wednesday, March 13, 2024Prilenia Therapeutics BV a company specializing in the development of innovative therapies for neurodegenerative diseases and neurodevelopmental disorders has announced its intention to submit a Marketing Authorization Application
Astrocyte Pharmaceuticals Receives FDA Clearance for Investigational New Drug Application for AST-004
Wednesday, March 13, 2024Astrocyte Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on developing therapies for stroke traumatic brain injury and concussion has announced that the US Food and Drug Administration
Pearl Bio Enters Collaboration with Merck for Discovery of Innovative Engineered Biologics
Wednesday, March 13, 2024Pearl Bio a synthetic biology company supported by Khosla Ventures has announced a significant partnership today with Merck known as MSD outside the United States and Canada The collaboration involves a license
Merck's Acquisition of Harpoon Therapeutics, Inc. Successfully Concluded
Tuesday, March 12, 2024Merck also known as MSD outside of the United States and Canada has successfully completed its acquisition of Harpoon Therapeutics Inc Following this acquisition Harpoon now operates as a whollyowned subsidiary of Merck and its common stock is no lon...
Ubiquigent Announces Collaboration with Nanna Therapeutics, a Subsidiary of Astellas
Tuesday, March 12, 2024Ubiquigent Limited a company specializing in drug discovery and development focusing on innovative deubiquitinase modulators to address significant medical needs has announced a partnership
Terns Pharmaceuticals Secures Orphan Drug Designation for TERN-701 in Chronic Myeloid Leukemia Treatment
Monday, March 11, 2024Terns Pharmaceuticals Inc a clinicalstage biopharmaceutical company specializing in the development of smallmolecule treatments for severe diseases like oncology and obesity
Wegovy® Approved in the US for Mitigating Cardiovascular Risks Among Individuals with Overweight or Obesity and Established Cardiovascular Disease
Saturday, March 09, 2024Novo Nordisk announced today that the US Food and Drug Administration has approved a label expansion for Wegovy based on a supplemental New Drug Application This expansion
Cellipont Bioservices Announces Opening of New Facility for Manufacturing Cell Therapies
Friday, March 08, 2024Cellipont Bioservices is excited to announce the opening of its advanced sq ft manufacturing facility in The Woodlands TX The facility features clean rooms QC labs temperaturecontrolled storage
Upstream Bio Launches Phase 2 Trial for Verekitug (UPB-101) in Severe Asthma, Administers Initial Doses to Patients
Friday, March 08, 2024Upstream Bio a clinicalstage biotech company focusing on developing new therapies for inflammation has announced the initiation of dosing for the first patients in its Phase VALIANT clinical trial of verekitug
